- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Responding to a series of AOL News articles questioning the oversight of nanotechnology product safety (www.aolnews.com/category/nanotech/), nanoTox COO Greg King said that nano-product companies will need to confront possible negative perceptions directly to avoid the kinds of public outcry experienced by bioengineered food companies in the past.
"It's in people's nature to fear the unknown," said King. "And while companies may not be able to educate everyone in the complexities of nanotechnology, they can turn safety concerns to their advantage by being transparent about its use in their products, documenting their careful research and emphasizing concern over human and environment health."
King was responding to AOL News and Pulitzer Prize-winning reporter Andrew Schneider, who published a series entitled "The Nanotech Gamble" which explored possible risks that may accompany nanotechnology research and product development. Schneider's series was greeted with concern by most in the U.S. nanoproduct industry.
"Schneider's articles expresses quite well the public's concern about nanomaterials," King added. "No new technology gains wide consumer acceptance until potential safety concerns are addressed and resolved.
"Companies wanting to successfully commercialize products that contain nanomaterials will need to address those safety concerns. This is especially true for nanoproducts that have direct human contact, such as textiles, foods, medicines, cosmetics, personal care products. The companies that can demonstrate that their products are safe will have a competitive advantage."
King is the author of several articles on nanotechnology risk management and nanotechnology regulation. King's company, nanoTox, is the first to provide complete risk assessment and solutions exclusively for nanoparticles.
"The nanotech revolution is one of the best opportunities for cosmetic, food, and other companies incorporating nanoparticles to build new trust with their existing and future customers," said King. "By showing that they are ahead of the game, they can inoculate themselves against negative perceptions and even champion themselves as leaders in product safety."
nanoTox is the first company to provide complete risk assessment – and solutions – exclusively for nanoparticles. nanoTox can help companies commercialize their products by helping address safety issues and responding to regulatory requirements.
nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.
nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.
For more information, please click here
Copyright © nanoToxIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016
PEN Inc. Announces Strategy to Broaden Clarity Branded Products Business February 4th, 2016
Graphenea increases capacity, reduces prices January 25th, 2016
The impact of anti-odor clothing on the environment March 31st, 2016
SUNY Poly, in Collaboration with the George Washington School of Medicine and Health Sciences and Stony Brook University, Demonstrates Pioneering Method to Visualize and Identify Engineered Nanoparticles in Tissue March 25th, 2016